HEARTS Trial for Thoracic Cancers

The HEARTS trial is testing whether a heart-sparing radiation technique can reduce heart-related side effects in patients with thoracic (chest) cancers — including lung cancer, esophageal cancer, and thymoma — who receive radiation therapy as part of their treatment. **You may be eligible if...** - You are over 18 years old - You have a thoracic cancer such as non-small cell lung cancer (stage IIB–IV, inoperable), limited-stage small cell lung cancer, esophageal or esophagogastric cancer, or thymoma/thymic carcinoma - Your radiation treatment plan shows that a meaningful portion of your heart would receive a significant dose of radiation (based on planning calculations) - Your diagnosis has been confirmed by tissue or cell sample **You may NOT be eligible if...** - Your heart would not receive significant radiation based on the treatment plan - You have conditions that would make this specialized radiation technique unsafe Talk to your doctor to see if this trial is right for you.